Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Verteporfin PDT for Neovascular AMD
NCT00347399Phase 2Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Mar 2006
- Primary completion
- Jun 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in neovascular age-related macular degeneration (NVAMD), sponsored by Asociación para Evitar la Ceguera en México. Started Mar 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT00347399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347399.